Catalog Advanced Search
-
Contains 28 Component(s), Includes Credits
The American College of Clinical Pharmacology® monthly journal article continuing education offerings from The Journal of Clinical Pharmacology.
Registration and Pricing
The American College of Clinical Pharmacology® (ACCP) offers a monthly article from the The Journal of Clinical Pharmacology (JCP) for continuing education credit. See the CE Info tab for more information on credits. The ACCP JCP Journal CE articles are priced and packaged for January through December of the same calendar year. Packages are available at no cost to ACCP Members and $75/calendar year to Non-members. Once registered, learners have access to all of the Journal CE articles for the calendar year as the articles are released.
To register, log into your ACCP online profile and then register by clicking the green Register button at the top right. Follow the online prompts to complete the registration process and to receive your registration confirmation. If you do not have an ACCP profile, one must be created before you can register for the Journal CE articles. If you do not know if you have a profile, please contact KLevy@ACCP1.org for further information to avoid creating duplicate profiles. Please address all other questions to CE@ACCP1.org.
Requirements for Credits
All requirements for claiming CE credits are listed in the CE Info tab. Continuing education credits and certificates must be claimed within 30-days of completing the monthly article offering. Continuing Pharmacy Education (CPE) data is uploaded into the CPE Monitor at the end of each month. The pharmacist's NABP# and MMDD of birth must be updated into their ACCP Profile or emailed to CE@ACCP1.org in order to have CPE credits automatically uploaded to the CPE Monitor.
CE Expiration 12/31/2025
-
You must log in to register
- User - $75
- Member - Free!
- More Information
-
You must log in to register
-
Contains 4 Component(s), Includes Credits
This clinical webinar will be describing the essentials and applications of clinical pharmacology in opioid-sparing techniques for analgesia with emphasis on local anesthetics and discussing advances and challenges of these techniques in adult and pediatric settings.
ACCP 2022 Clinical Practice Webinar - Clinical Pharmacology of Non-opioid Analgesia-On Demand
On-demand webinar recording: May 19, 2022 to May 19, 2025
Why is this article important to your practice?
This clinical webinar will be describing the essentials and applications of clinical pharmacology in opioid-sparing techniques for analgesia with emphasis on local anesthetics and discussing advances and challenges of these techniques in adult and pediatric settings.
Target Audience:
Physicians, Pharmacists, PhDs and healthcare professionals interested in clinical pharmacology.
Learning Objectives:
After completing this activity, the learner will be able to:
1. Describe the clinical use and mechanisms of action of the most common local anesthetic agents;
2. Assess contraindications, safety and adverse events of various local anesthetics;
3. Review pharmacokinetic data and the influence of developmental pharmacology;
4. Discuss pharmacodynamic differences in response to local anesthesia and modification of pharmacodynamics by additives.
Claude Abdallah, MD
Anesthesiologist
Children's National Health System
Dr. Abdallah is a Pediatric Anesthesiologist, Associate Professor, at Children's National Health System. Dr. Abdallah joined ACCP in 2013 and was actively involved in the Honors & Award Committee from 2014 – 2016. She then joined the Education Committee in 2016. Dr. Abdallah received an MD from St Joseph's Univ Medical School in Beirut, Lebanon and then received her Master's in Pharmacology from Université de Montréal, Canada. She performed her residency in Anesthesiology at Yale-New Haven Hosp followed by a fellowship in pediatric anesthesia at the Hosp for Sick Children, Toronto, Canada. She has authored several publications in peer reviewed journals, abstracts and presented her research regionally, nationally and internationally at educational and organizational venues. She has been in practice for more than 15 years and has an interest in clinical research and pharmacology.
-
You must log in to register
- User - Free!
- Member - Free!
- More Information
-
You must log in to register
-
Contains 1 Component(s)
Students, Trainees & Early-stage Professionals are encouraged to attend this event and hear from a diverse background of panelists who will share various elements of their career journeys and pivotal decisions related to mentorship, leadership, academic excellence and networking.
ACCP Students, Trainees & Early-stage Professionals Webinar: Lead the Way - With the Next STEP in Your Career - ON DEMAND
On-demand webinar recording: April 21, 2022 to April 21, 2027
Why is this webinar important to you?
Students, Trainees & Early-stage Professionals are encouraged to attend this event and hear from a diverse background of panelists who will share various elements of their career journeys and pivotal decisions related to mentorship, leadership, academic excellence and networking.
Target Audience:
Students, Trainees & Early-stage Professionals.
Learning Objective:
After completing this activity, the learner will be able to:
- Learn how to establish a network that supports your career over time;
- Understand the importance of strategically developing a team of mentors to support your career growth and know when it's time to give back by serving as a mentor;
- Recognize the opportunities to develop skills that foster academic excellence by participation in ACCP-sponsored events;
- Learn how to build leadership skills and influence without authority.
-
You must log in to register
- User - Free!
- Member - Free!
- More Information
-
Contains 5 Component(s), Includes Credits
Presented by: Christina R. Chow, PhD, Head of Research, Emerald Lake Safety
Impact of Obesity on Brexpiprazole Pharmacokinetics: Proposal for Improved Initiation of Treatment-ON DEMAND
ACCP Virtual Journal Club Webinars
On Demand: March 16, 2022 to March 16, 2025
See Handouts tab for Continuing Education information on CME and CPE credits.
Why is this webinar important to you?
Brexpiprazole is an oral antipsychotic agent indicated for use in patients with schizophrenia or as adjunctive treatment for major depressive disorder.
As obesity (body mass index ≥35 kg/m2) has the potential to affect drug pharmacokinetics and is a common comorbidity of both schizophrenia
and major depressive disorder, it is important to understand changes in brexpiprazole disposition in this population. This study uses a whole-body
physiologically-based pharmacokinetic (PBPK) model to compare the pharmacokinetics of brexpiprazole in obese and normal-weight (body mass index 18-
25 kg/m2) individuals known to be cytochrome P450 2D6 extensive metabolizers and poor metabolizers (PMs).Target Audience
Physicians, Pharmacists, PhDs and Physician Assistants.Learning Objectives
After completing this activity, the learner will be able to:1) Explain the relationship between obesity, Brexpiprazole pharmacokinetics and clinical outcome;
2) Articulate the relationship between PMs, Brexpiprazole dosing and clinical outcome;
3) Learn about the PBPK model.To receive credit, learners must attend the complete live webinar or view the complete on-demand webinar; complete a post-course assessment and evaluation.
Christina Chow, PhD
Head of Research
Emerald Lake Safety
Christina Chow has spent her entire career in pharmacology research. At Emerald Lake Safety, Dr. Chow leads collaborations with external scholars and researchers on clinical studies and scientific analyses. Before joining the ELS team, Dr. Chow was a Postdoctoral Fellow at the Robert H. Lurie Comprehensive Cancer Center at Northwestern University and a former Visiting Research Specialist at the Research Center for Advanced Science and Technology at The University of Tokyo. Dr. Chow received her PhD in Pharmacology at the University of Illinois at Chicago.
-
You must log in to register
- User - Free!
- Member - Free!
- More Information
-
You must log in to register
-
Contains 5 Component(s), Includes Credits
Presented by: Catherijne AJ Knibbe, PhD, PharmD
Quantifying the Pharmacodynamics of Morphine in the Treatment of Postoperative Pain in Preverbal Children-LIVE
ACCP Virtual Journal Club Webinars
Live Webinar: August 10, 2022, 2:00 - 3:00 PM ET
On Demand: August 10, 2022 to August 10, 2025
See Handouts tab for Continuing Education information on CME and CPE credits.
Why is this webinar important to you?
There is only limited study into the pharmacodynamics of morphine for postoperative use in children, while the pharmacokinetics of morphine has been studied extensively. The effects of morphine in children after surgery are generally registered using behavior pain scales like the COMFORT-Behavior (COMFORT-B) scale. This scale consists of six behavioral items that quantify pain-associated behavior and symptoms as a proxy for the level of pain, each ranging from 1 (low distress/pain) to 5 (high distress/pain). As such, the total COMFORT-B score ranges from 6 to 30, for which scores of 11 to 16 are clinically aimed for during titration. To quantify the concentration-effect relationship of morphine for postoperative pain in preverbal children between 0 and 3 years of age, we applied Item Response Theory modeling in the pharmacokinetic/pharmacodynamic analysis of COMFORT-B scale data from two previous pediatric clinical studies. Learners that complete this course, will be able to explain the pharmacodynamics of morphine across the pediatric age range.
Target Audience
Physicians, Pharmacists, PhDs and Physician Assistants.Learning Objectives
After completing this activity, the learner will be able to:1) Define the target concentration of morphine throughout childhood;
2) Identify non-responders to morphine up-titration.
To receive credit, learners must attend the complete live webinar or view the complete on-demand webinar; complete a post-course assessment and evaluation.
Catherijne Knibbe, PhD, PharmD
Professor
St Antonius Hosp/Leiden Univ
Catherijne Knibbe, PharmD, PhD is Professor of Individualized Drug Treatment at the Division of Systems Pharmacology and Pharmacy of the LACDR, Leiden University, and clinical pharmacologist-hospital pharmacist at the Department of Clinical Pharmacy of the St. Antonius Hospital, Nieuwegein, the Netherlands. She also holds a guest appointment at the Erasmus MC, Sophia Childrens Hospital Rotterdam.
Dr. Knibbe’s primary research focus is to optimize individualized drug treatment for special patient populations such as neonates and children, the elderly and morbidly obese pediatric and adult patients. To this end, she applies advanced statistical and pharmacometric approaches such as population PKPD modelling and PBPK modelling, to existing or newly derived data. To obtain these data, she has designed and conducted a large number of clinical studies not only within her own institution but also with many collaborating hospitals in Europe and the US, supported by different grant mechanisms. She has successfully supervised 23 PhD students, and currently is supervising 10 PhD students and 3 Post Docs/Assistant Professors. She is a co-author of over 250 international peer-reviewed publications and contributions to books. Catherijne is frequently invited to speak at national and international scientific meetings. In the St. Antonius Hospital, besides being member of the Daily Board, she directs the Clinical Pharmacology training program and the Hospital Pharmacy training program. In addition she is a clinical pharmacology consultant for the departments of Intensive Care and Anesthesiology. She serves on different national and international committees including the Board of the American College of Clinical Pharmacology.
Nothing to disclose.
-
You must log in to register
- User - Free!
- Member - Free!
- More Information
-
You must log in to register
-
Contains 3 Component(s)
Cobimetinib is a kinase inhibitor indicated for use in combination with vemurafenib for treatment of unresectable/metastatic melanoma with specific BRAF mutations. Cobimetinib is extensively metabolized in liver; thus, patients with hepatic impairment (HI) might have increased cobimetinib exposure. By attending this educational activity, you will learn about the impact of HI on the pharmacokinetics (PK) and safety of cobimetinib.
2021 ACCP Virtual Journal Club Webinar: Effect of Hepatic Impairment on Cobimetinib Pharmacokinetics: The Complex Interplay Between Physiological Changes and Drug Characteristics - On Demand
On-demand webinar recording: December 8, 2021 to December 8, 2024
Why is this article important to your practice?
Cobimetinib is a kinase inhibitor indicated for use in combination with vemurafenib for treatment of unresectable/metastatic melanoma with specific BRAF mutations. Cobimetinib is extensively metabolized in liver; thus, patients with hepatic impairment (HI) might have increased cobimetinib exposure. By attending this educational activity, you will learn about the impact of HI on the pharmacokinetics (PK) and safety of cobimetinib.
Target Audience:
Interprofessional team of Physicians, Pharmacists, PhDs, Nurse Practitioners and Physician Assistants.
-
You must log in to register
- User - Free!
- Member - Free!
- More Information
-
You must log in to register
-
Contains 48 Component(s), Includes Credits
The American College of Clinical Pharmacology® monthly journal article continuing education offerings from The Journal of Clinical Pharmacology.
Registration and Pricing
The American College of Clinical Pharmacology® (ACCP) offers a monthly article from the The Journal of Clinical Pharmacology (JCP) for continuing education credit. See the CE Info tab for more information on credits. The ACCP JCP Journal CE articles are priced and packaged for January through December of the same calendar year. Packages are available at no cost to ACCP Members and $75/calendar year to Non-members. Once registered, learners have access to all of the Journal CE articles for the calendar year as the articles are released.
To register, log into your ACCP online profile and then register by clicking the green Register button at the top right. Follow the online prompts to complete the registration process and to receive your registration confirmation. If you do not have an ACCP profile, one must be created before you can register for the Journal CE articles. If you do not know if you have a profile, please contact KLevy@ACCP1.org for further information to avoid creating duplicate profiles. Please address all other questions to CE@ACCP1.org.
Requirements for Credits
All requirements for claiming CE credits are listed in the CE Info tab. Continuing education credits and certificates must be claimed within 30-days of completing the monthly article offering. Continuing Pharmacy Education (CPE) data is uploaded into the CPE Monitor at the end of each month. The pharmacist's NABP# and MMDD of birth must be updated into their ACCP Profile or emailed to CE@ACCP1.org in order to have CPE credits automatically uploaded to the CPE Monitor.
CE Expiration 12/31/2024
-
You must log in to register
- User - $75
- Member - Free!
- More Information
-
You must log in to register
-
Contains 2 Component(s)
Presented by: Joseph S. Bertino Jr., PharmD, FCP, FCCP, Editor-in-Chief, The Journal of Clinical Pharmacology and David J. Greenblatt MD, FCP, Editor-in-Chief Clinical Pharmacology in Drug Development. This webinar provides professional training on performing scientific journal manuscript peer reviews.
ACCP Webinar - How to be a GREAT Journal Peer Reviewer
Why is this article important to your practice?
At the completion of this webinar participants will have a strong understanding and the skills to properly review a scientific manuscript, a professional competency applicable to journal peer reviewing across professions. Topics to be covered include: why one should serve as peer reviewer; the purpose of manuscript reviews; aspects of a great review; when to decline a review; confidentiality; a technical guide for reviews for each section of the manuscript; and writing the review.
Target Audience:
Researchers, Physicians, Pharmacists, and other professionals requiring training in the professional competencies of peer reviewing.
Learning Objectives:
After completing this activity, the learner will be able to:
- Describe why the peer review process is important;
- Explain how to review various sections of a scientific manuscript;
- Identify elements of writing a review that will be of benefit to the authors and to the Editor of the Journal.
Joseph S. Bertino, Jr, PharmD, FCP, FCCP
Editor-in-Chief
Bertino Consulting
Dr. Joseph S. Bertino is currently a Principal at Bertino Consulting. He is an Associate Professor of Pharmacology at the College of Physicians and Surgeons, Columbia University, and an Adjunct Associate Professor at the University at Buffalo School of Pharmacy. He is also an Honorary Professor, Hanoi University of Pharmacy and a Distinguished Professor of the Hai Phong University of Medicine and Pharmacy. He has published over 100 original research papers, review articles and book chapters including work in the area of antimicrobial pharmacokinetics, pharmacodynamics and toxicity, drug-drug interactions, general clinical pharmacology, vaccine pharmacology and the application of pharmacogenetics and pharmacogenomics to the drug development process. He serves as the Editor-in-Chief of The Journal of Clinical Pharmacology.
David J. Greenblatt, MD
Professor
Tufts Univ School of Medicine
Dr. David J. Greenblatt holds the Louis Lasagna, MD, Endowed Professorship at Tufts University School of Medicine, in the Department of Immunology, and is a Senior Faculty Member in the Graduate Program in Pharmacology & Experimental Therapeutics at the Sackler School of Graduate Biomedical Sciences at Tufts University. He also holds appointments as Professor of Psychiatry, Medicine and Anesthesia. He has previously served as Chair of the Department of Pharmacology and Experimental Therapeutics, Program Director and Associate Program Director of the institution’s Clinical/Translational Research Center (formerly the General Clinical Research Center) and Chair of the Institutional Review Board. He is Editor-in-Chief of Clinical Pharmacology in Drug Development, a journal of the American College of Clinical Pharmacology. He also is Co-Editor-in-Chief, with Dr. Richard I. Shader, of the Journal of Clinical Psychopharmacology.
-
You must log in to register
- User - Free!
- Member - Free!
- More Information
-
Contains 5 Component(s), Includes Credits
Presented by: Christine Xu, PhD, Director, Translational Medicine & Early Development, Sanofi
Differential Binding of Sarilumab and Tocilizumab to IL-6Rα and Effects of Receptor Occupancy on Clinical Parameters- On Demand
ACCP Virtual Journal Club Webinars
On Demand: August 18, 2021 to August 18, 2024
See Handouts tab for Continuing Education information on IPCE credits.
Why is this webinar important to you?
This webinar presents the bridging through pharmacokinetic/pharmacodynamic modeling the in vitro binding affinity to in vivo receptor occupancy and the potential association with clinical parameter improvements of sarilumab and tocilizumab in patients with rheumatoid arthritis. The study evaluated the in vitro binding of sarilumab and tociluzumab to interleukin (IL)-6Rα and inhibition of signaling and the association between IL-6Rα receptor occupancy and C-reactive protein (CRP) and potential clinical relevance of differences.
Target Audience
Interprofessional team of Physicians, Pharmacists, PhDs, Nurse Practitioners and Physician Assistants.Learning Objectives
After completing this activity, the learner will be able to:1) Articulate the mechanism of action of sarilumab and tocilizumab and the downward physiologic effects;
2) Differentiate the binding affinity of sarilumab and tocilizumab to IL-6Rα compared to placebo;
3) Evaluate the expected response to CRP levels and the expected clinical response based on dosage and usage of sarilumab and tocilizumab.To receive credit, learners must attend the complete live webinar or view the complete on-demand webinar; complete a post-course assessment and evaluation.
-
You must log in to register
- User - Free!
- Member - Free!
- More Information
-
You must log in to register
-
Contains 1 Component(s)
ACCP is a flagship society with a global reach and offers a wealth of benefits for its Members. Unfortunately, the full array of benefits available to Members and how best to leverage them may not be fully recognized. This webinar will inform Members, or those considering membership, of the diverse benefits available through ACCP. Using their own experiences, our Faculty Speakers will discuss Member Benefits and note the various professional milestones one can achieve through society involvement. Specific topics will include career advancement, educational opportunities, as well as gaining visibility and finding community in the field of clinical pharmacology. As the professional needs of ACCP Members tend to change throughout a career trajectory, our Faculty Speakers have been selected to represent viewpoints from early, mid and senior-level career stages. In addition to being recognized as leaders and experts in their disciplines, each of our Faculty Speakers has extensive experience within ACCP.
ACCP Webinar - How to Make ACCP Member Benefits Work for YOU! - ON DEMAND
Live webinar: June 16, 2021 from 2:00 - 3:30 PM ET
On-demand webinar recording: June 16, 2021 to June 16, 2024
Why is this article important to your practice?
ACCP is a flagship society with a global reach and offers a wealth of benefits for its Members. Unfortunately, the full array of benefits available to Members and how best to leverage them may not be fully recognized. This webinar will inform Members, or those considering membership, of the diverse benefits available through ACCP. Using their own experiences, our Faculty Speakers will discuss Member Benefits and note the various professional milestones one can achieve through society involvement. Specific topics will include career advancement, educational opportunities, as well as gaining visibility and finding community in the field of clinical pharmacology. As the professional needs of ACCP Members tend to change throughout a career trajectory, our Faculty Speakers have been selected to represent viewpoints from early, mid and senior-level career stages. In addition to being recognized as leaders and experts in their disciplines, each of our Faculty Speakers has extensive experience within ACCP.
Kacey B. Anderson, PhD
Senior Clinical Pharmacologist II
Gilead Inc
Dr. Anderson received her PhD in Pharmaceutical Sciences from the University of Pittsburgh. After graduating, she joined the Department of Clinical Pharmacology at Gilead Sciences in San Francisco, CA where she currently works as a Senior Clinical Pharmacologist II. In this role, Dr. Anderson is the lead clinical pharmacologist supporting several development programs for inflammation small molecules. Dr. Anderson joined ACCP in 2013 and is an active participant in the organization. She was diligently involved in the Student, Trainee & Early-stage Professional Committee since 2014 and led the committee as Co-chair from 2016 to 2019. More recently, she has served as a member of the Membership Committee (2019 – present) and the Annual Meeting Program Committee (2021 – present) and is currently participating in the Leadership Development Program. Furthermore, Dr. Anderson has also supported the society by manuscript submissions to the Clinical Pharmacology in Drug Development journal and attending and presenting at the Annual Meeting.
Ayyappa Chaturvedula, PhD
Associate Professor of Pharmacotherapy
Univ of North Texas System Coll of Pharmacy
Dr. Chaturvedula is currently working as Director, Clinical Pharmacology at Arcus Biosciences from June 2021. He also holds a position as an Associate Professor of Pharmacotherapy to teach in fully online Pharmacometrics certificate program at the UNT health science center at Fort Worth. He received bachelor’s in pharmacy from the University College of Pharmaceutical Sciences (UCPSC), Kakatiya University, India and PhD in Pharmaceutical Sciences from Mercer University, Atlanta, GA. He received advanced training in pharmacometrics as a visiting scientist in the Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California San Francisco, in association with the Center for Drug Development Science (CDDS). He has been awarded with 2020 Tanabe Young Investigator award by the American College of Clinical Pharmacology (ACCP).
Michael W. Jann, PharmD
Professor, Pharmacotherapy
Univ of North Texas System Coll of Pharmacy
Michael W. Jann, PharmD, FCP is Professor of Pharmacotherapy at the UNT SCP. Dr. Jann served as the UNTSCP Chair for the Dept of Pharmacotherapy from May 2013 to December 2017. Dr. Jann served as Chair for the Dept of Pharmacy Practice from July 2002 to May 2013 and held a cross appointment as Professor of Pharmaceutical Sciences at Mercer Univ Coll of Pharmacy & Health Sciences in Atlanta, GA. Dr. Jann held Mercer Univ’s Endowed Chair in Neuropsychopharmacology. The author or co-author of over 250 book chapters, peer-review articles and scientific abstracts. He is a member on the editorial boards of CNS Drugs, Journal of Pharmacy Practice, Molecular Diagnostics and Therapeutics, Consultant Pharmacist, The Scientific World Journal – Pharmacology Section and The Journal of Clinical Pharmacology.
-
You must log in to register
- User - Free!
- Member - Free!
- More Information
-
You must log in to register